NEMO - Nano-based capsule-Endoscopy with Molecular Imaging and Optical biopsy

 

The objective of the NEMO project is to develop an advanced cancer screening system that is patient-friendly, highly sensitive and specific for early detection of gastrointestinal cancer.  The NEMO project will adopt converging technologies combining optical imaging technologies with novel nano-technologies for biosensing, maneuvering and ultra low power miniaturization to create a unique wireless capsule endoscope including an array of immunoassay methods for the detection of surface and deeper tissue pathology, especially cancer.. 

 

Partners

 

NEMO is a three year project funded by the European Commission of the Sixth EU Framework Program of Research and Technological Development (“FP6 commission”) consisting of the following partners:

 

Given Imaging Ltd (Israel)

Zarlink Semiconductor (Sweden and UK)

The Hebrew University in Jerusalem (Israel)

Fraunhofer Institute for Biomedical Engineering (Germany)

Fondazione Bruno Kessler - IRST, Research Institute (Italy)

Israelitisches Krankenhaus (Germany)

Imperial College of Science, Technology and Medicine (London, England)

Innova Proteomics (Germany)

Fundeni Clinical Institute (Germany)

NovaMed (Israel)

Ernst & Young (Israel)